123 related articles for article (PubMed ID: 9154500)
1. Clinical diagnostic accuracy of faecal occult blood test for anal diseases.
Nakama H; Kamijo N; Fujimori K; Horiuchi A; Fattah AS; Zhang B
Int J Qual Health Care; 1997 Apr; 9(2):139-41. PubMed ID: 9154500
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical fecal occult blood test is not suitable for diagnosis of hemorrhoids.
Nakama H; Kamijo N; Fujimori K; Horiuchi A; Abdul Fattah S; Zhang B
Am J Med; 1997 Jun; 102(6):551-4. PubMed ID: 9217670
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
4. Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients.
Kaul A; Shah A; Magill FH; Hawkins SA; Skaife P
Int J Surg; 2013; 11(4):329-31. PubMed ID: 23459187
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of faecal occult blood tests requested outside the UK National Bowel Cancer Screening Programme.
McDonald R; Tomlins A; Smith S; Harmston C
J Clin Pathol; 2013 Apr; 66(4):330-4. PubMed ID: 23288919
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
Damery S; Clifford S; Wilson S
BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the fecal occult blood test and benign anal disorders.
Sasaki K; Kunimoto M; Hirata K
Hepatogastroenterology; 2001; 48(38):445-7. PubMed ID: 11379329
[TBL] [Abstract][Full Text] [Related]
11. Effect of faecal occult blood positivity on detection rates and positive predictive value of CT colonography when screening for colorectal neoplasia.
Plumb AA; Taylor SA; Halligan S
Clin Radiol; 2015 Oct; 70(10):1104-9. PubMed ID: 26145187
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
[TBL] [Abstract][Full Text] [Related]
13. A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer.
Gillberg A; Ericsson E; Granstrom F; Olsson LI
Colorectal Dis; 2012 Sep; 14(9):e539-46. PubMed ID: 22738077
[TBL] [Abstract][Full Text] [Related]
14. Digital rectal examination sampling of stool is less predictive of significant colorectal pathology than stool passed spontaneously.
Nakama H; Fattah AS; Zhang B; Kamijo N
Eur J Gastroenterol Hepatol; 2000 Nov; 12(11):1235-8. PubMed ID: 11111781
[TBL] [Abstract][Full Text] [Related]
15. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England.
He E; Alison R; Blanks R; Pirie K; Reeves G; Ward RL; Steele R; Patnick J; Canfell K; Beral V; Green J
Int J Epidemiol; 2019 Apr; 48(2):549-558. PubMed ID: 30668711
[TBL] [Abstract][Full Text] [Related]
16. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
[TBL] [Abstract][Full Text] [Related]
17. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
18. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
19. Relationships between a sign of rectal bleeding and the results of an immunochemical occult blood test, and colorectal cancer.
Nakama H; Zhang B; Abdul Fattah AS; Kamijo N; Fukazawa K
Eur J Cancer Prev; 2000 Oct; 9(5):325-8. PubMed ID: 11075885
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of self-reports of fecal occult blood tests and test results among individuals in the carpentry trade.
Lipkus IM; Samsa GP; Dement J; Skinner CS; Green LS; Pompeii L; Ransohoff DF
Prev Med; 2003 Nov; 37(5):513-9. PubMed ID: 14572436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
